Arrowhead Pharmaceuticals, Inc.

D. E. Shaw & Co., Inc. ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

146,064

Value ($000)

9,697

Weight

0.0%

2019 Q4 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	9,697	0.0%	146,064	12/31/2025
2025 Q3	11/14/2025	700	0.0%	20,301	9/30/2025
2023 Q4	2/14/2024	1,392	0.0%	45,474	12/31/2023
2023 Q2	8/14/2023	1,119	0.0%	31,390	6/30/2023
2023 Q1	5/15/2023	776	0.0%	30,563	3/31/2023
2022 Q2	8/15/2022	288	0.0%	8,189	6/30/2022
2021 Q4	2/14/2022	2,196	0.0%	33,117	12/31/2021
2021 Q3	11/15/2021	2,616	0.0%	41,906	9/30/2021
2021 Q2	8/16/2021	5,003	0.0%	60,412	6/30/2021
2021 Q1	5/17/2021	2,930	0.0%	44,185	3/31/2021
2020 Q4	2/16/2021	6,799	0.0%	88,599	12/31/2020
2020 Q3	11/16/2020	11,324	0.0%	262,972	9/30/2020
2020 Q2	8/14/2020	18,724	0.0%	433,518	6/30/2020
2020 Q1	5/15/2020	19,452	0.0%	676,121	3/31/2020
2019 Q4	2/14/2020	43,950	0.1%	692,895	12/31/2019